The European Medicines Agency could issue a recommendation on Moderna’s coronavirus vaccine sooner than Wednesday, as originally planned, according to the regulator.
The EMA’s human medicines committee (CHMP) is meeting Monday to discuss the Moderna vaccine. An EMA spokesperson told POLITICO in an email that in case the panel reaches an opinion then, “we would send out a press release as soon as possible after the meeting.”
“The CHMP meeting scheduled for Wednesday, 6 January, is also still planned in case the committee does not reach a decision today,” the spokesperson added.
The EMA is also organizing a public meeting on January 8 to inform EU citizens about the assessment, approval and roll out of the new vaccines, the spokesperson noted.
The earlier time frame comes as the EU faces increasing criticism for a slow vaccination rollout, with some in Germany blaming the Commission for purchasing too few vaccines and the EMA for issuing recommendations too slowly.
The U.S. issued an emergency authorization of the Moderna jab on December 19.
Meanwhile, the EU issued a conditional marketing authorization for the BioNTech/Pfizer coronavirus vaccine on December 21.